AI Proteins
@AI_Proteins
better medicines, created rapidly through de novo protein design
Exciting times at @AI_Proteins! We are getting so close to see our drugs helping patients! fiercebiotech.com/biotech/bristo…
It was an honor to speak from the main stage at @TEDTalks last week about our work at @AI_Proteins
I am so grateful to be back on the TED stage this week in Vancouver to share an update on our story. In the 6 years since my last TED talk, I left academia and founded AI Proteins. I can't wait to tell you about what we've been building. businesswire.com/news/home/2025…
Welcome Phil Brandish, Chief Development Officer, to the AI Proteins team! businesswire.com/news/home/2025…
Biotechnology firm @AI_Proteins has partnered with the @Mizzou to advance the use of de novo designed miniproteins for targeted radioligand cancer therapy using its AI-powered platform. aibusiness.com/health-care/ai…
We're delighted to share that our #Founder Chris Bahl @bahl_lab is now our CEO! businesswire.com/news/home/2025…
I’m excited to share that I am now the CEO of @AI_Proteins! I’m grateful to continue leading this exceptional team as we build upon the strong foundation that we’ve established since launching the company in 2021. businesswire.com/news/home/2025… 🧵👇
So, I might have ended up on the jumbotron at the Celtics game proudly wearing my @AI_Proteins colors
See Mireia Solà Colom @MireiaSol6, Head of Immunotherapeutics at @AI_Proteins, as she presents our latest progress on the design and optimization of immune cell engagers built from our de novo #miniproteins
for the folks who weren't able to join for @MireiaSol6's brilliant presentation last week to cap off our 2024 seminar series, you can check out the recording 👇 youtu.be/e6oZgGWjD_0
We've got some very exciting news to share! businesswire.com/news/home/2024… and here's a 🧵 about the journey from academia to @AI_Proteins
We're excited that Mireia Solà Colom @MireiaSol6, our Head of Immunotherapeutics will share some of our latest work on immune cell engagers at @ProteinBoston next month!
There's just one meeting left in 2024, and we have a spectacular seminar by @MireiaSol6 lined up for you! Join us at 7pm in Room 181, Building 68, MIT on Wednesday, December 11th. "De novo design of miniprotein-based natural killer cell engagers" bpdmc.org
Our founder, President and CSO Chris Bahl @bahl_lab went to the @Falling_Walls Science Summit last week to explain how we make #miniprotein therapeutics with unprecedented ability to control cellular behavior - you can check out the recording 👇 youtube.com/live/zB6-iUB9z…
Excited to share that a de novo designed miniprotein that myself, @bahl_lab, and @frankteets created during my post-doc is now in humans! The miniprotein is a Nectin-4 binding radiopharmaceutical being developed by Aktis Oncology.
so excited that our field of protein design has been awarded a @NobelPrize, and it's amazing to see my postdoc advisor receive this very well-deserved recognition!! and congrats to all of the brilliant and insightful researchers who made key contributions to these breakthroughs!
BREAKING NEWS The Royal Swedish Academy of Sciences has decided to award the 2024 #NobelPrize in Chemistry with one half to David Baker “for computational protein design” and the other half jointly to Demis Hassabis and John M. Jumper “for protein structure prediction.”
We are honored to be selected as a @Falling_Walls Venture winner! Our de novo designed #miniprotein therapeutics promise to be a game changer for patients, and this recognition is a testament to the hard work and dedication of our team
These science start-ups that will pitch for the title Falling Walls #ScienceBreakthrough of the Year 2024 at the #FallingWalls #ScienceSummit24: 🏆 ActiTrexx 🏆 AI Proteins @AI_Proteins 🏆 ARQUE Systems 🏆 Bioeutectics 🏆 Cyclize 🏆 DeepEn 🏆 ecoLocked 🏆 ElectraLith 🏆 Exazyme
I'm extremely grateful to the stellar team of collaborators that made it a joy to work on this story: @MireiaSol6 Jelena Vučinić @jadolfbr @binder_finder_ Sébastien Verel, Isabelle Moczygemba @thomasschiex @simoncini_david proudly published in @ProteinSociety's Protein Science
Excited to share work from @bahl_lab! When at IPI, the team used #AI to interrogate the functional sequence landscape of #proteinbinding sites in silico to better understand #COVID evolution & mitigation. Nice job & wishing you well, @AI_Proteins team! ➡️ onlinelibrary.wiley.com/doi/10.1002/pr…
Excited to share work from @bahl_lab! When at IPI, the team used #AI to interrogate the functional sequence landscape of #proteinbinding sites in silico to better understand #COVID evolution & mitigation. Nice job & wishing you well, @AI_Proteins team! ➡️ onlinelibrary.wiley.com/doi/10.1002/pr…